Opus Genetics, Inc.
IRD· Nasdaq
IRDOpus Genetics, Inc.
Filed Mar 16, 2015 · 10-K · 75 days after period end · 0001140361-15-011969
| Metric | Q4 2014 | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 |
| Net Income | -$2.21M | -$2.72M | -$55.40K | $389.28K |
| EPS Diluted | -$0.01 | — |
Opus Genetics, Inc. · CIK 1228627 · Engraved from SEC EDGAR
| — |
| — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2014 · filed Mar 16, 2015 · 75 d after period end
